Edgen Stock·Dec 29 2025, 12:28Back
Back
Merck to Acquire Cidara for $221.50/Share After Flu Drug Success
Edgen Stock·Dec 29 2025, 12:28
Enterprise Products Partners Nears Financial Inflection Point, Poised for Enhanced Shareholder ReturnsNov 28 2025, 10:17US-China AI Rivalry Enters New Phase Focused on Compute Power and CybersecurityNov 28 2025, 10:17Enterprise Products Partners Nears Financial Inflection Point, Poised for Enhanced Shareholder ReturnsNov 28 2025, 10:17